HARVARD BIOSCIENCE INC (HBIO)
SAB BIOTHERAPEUTICS, INC. (SABS)
SAB BIO Reports Q1 2026 Financial Results and Recent Business Highlights
ZEVRA THERAPEUTICS, INC. (ZVRA)
Zevra Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference
KARYOPHARM THERAPEUTICS INC. (KPTI)
Karyopharm to Participate at Upcoming Investor Conferences
XILIO THERAPEUTICS, INC. (XLO)
Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates
HARVARD BIOSCIENCE INC (HBIO)
Harvard Bioscience Announces First Quarter 2026 Financial Results
NAYAX LTD. (NYAX)
Nayax Reports First Quarter 2026 Results
PEDIATRIX MEDICAL GROUP, INC. (MD)
Exploration Midland complète une première tranche de 2,2 millions $ dans le cadre d’un placement privé
AMBIQ MICRO, INC. (AMBQ)
Ambiq Reports First Quarter 2026 Financial Results
SAGIMET BIOSCIENCES INC. (SGMT)
Sagimet Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates
BRIDGEBIO PHARMA, INC. (BBIO)
BridgeBio Submits NDA to FDA for Encaleret for Individuals Living with ADH1
VERASTEM, INC. (VSTM)
Verastem Oncology to Present at Upcoming Investor Conferences
REAL BROKERAGE INC (REAX)
Chartwell Realty LLC Brings 150 Agents and $500 Million in Annual Volume to The Real Brokerage
PEDIATRIX MEDICAL GROUP, INC. (MD)
Midland Exploration Completes a First Tranche of $2.2 Million Private Placement